News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lippa Arnold
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/20/2021 |
4
| Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.7, valued at
$340k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.72, valued at
$111.6k
|
|
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
| 03/24/2020 |
4
| Lippa Arnold (Exec. Chairman, CEO, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 4,500,000 shares
@ $0
Gifted 4,500,000 shares
@ $0 |
|
| 07/25/2019 |
4
| Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 970 options
@ $3.24, valued at
$3.1k
|
|
| 09/14/2018 |
4
| Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Bought 47,620 shares
@ $0
Gifted 47,620 shares
@ $0
Bought 47,620 warrants
@ $1.575, valued at
$75k
Gifted 47,620 warrants
@ $1.575, valued at
$75k
|
|
| 07/03/2018 |
4
| Lippa Arnold (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Bought 15 convertible preferred
@ $1000, valued at
$15k
Bought 8,625 warrants
@ $1.55, valued at
$13.4k
|
|
| 12/12/2017 |
4
| Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 559,595 options to buy
@ $1.45, valued at
$811.4k
Gifted 559,595 options to buy
@ $1.45, valued at
$811.4k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| Lippa Arnold (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 06/20/2016 |
4
| Lippa Arnold (Executive Chairman and CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Disposed of 15,000,000 options to buy
@ $0.025, valued at
$375k
Disposed of 10,000,000 options to buy
@ $0.0197, valued at
$197k
Disposed of 24,000,000 options to buy
@ $0.0227, valued at
$544.8k
|
|
| 04/04/2016 |
4
| Lippa Arnold (Executive Chairman and CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.|
Txns:
| Acquired 3,350,319 warrants
@ $0.0157, valued at
$52.6k
Granted 24,000,000 options to buy
@ $0.0227, valued at
$544.8k
|
|
|
|